- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.90 Å
- Oligo State
- homo-trimer
- Ligands
- 19 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-FUC.6: 3 residues within 4Å:- Chain A: A.699, E.1065, N.1067
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:A.699
NAG-NAG-FUC.16: 4 residues within 4Å:- Chain B: A.699, E.1065, K.1066, N.1067
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:A.699
NAG-NAG-FUC.26: 3 residues within 4Å:- Chain C: A.699, E.1065, N.1067
No protein-ligand interaction detected (PLIP)- 6 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-MAN.7: 4 residues within 4Å:- Chain A: N.1091, T.1093, H.1094, F.1096
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.8: 2 residues within 4Å:- Chain A: I.1125, N.1127
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.17: 4 residues within 4Å:- Chain B: N.1091, T.1093, H.1094, F.1096
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:F.1096
NAG-NAG-MAN.18: 1 residues within 4Å:- Chain B: N.1127
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.27: 4 residues within 4Å:- Chain C: N.1091, T.1093, H.1094, F.1096
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:F.1096
NAG-NAG-MAN.28: 1 residues within 4Å:- Chain C: N.1127
No protein-ligand interaction detected (PLIP)- 26 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.29: 2 residues within 4Å:- Chain A: Y.28, N.61
Ligand excluded by PLIPNAG.30: 5 residues within 4Å:- Chain A: N.122, T.124, N.125, V.127, E.154
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain A: K.147, N.149, S.151
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain A: E.132, N.165
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain A: N.273, N.275, T.277
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain A: N.336, V.360
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain A: N.596
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain A: N.650
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain A: N.702
- Chain B: D.789
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain A: N.1151
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain B: Y.28, N.61
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain B: K.147, N.148, N.149
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Chain B: N.234
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain B: N.324, T.326, Q.573
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain B: G.332, N.336
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain B: T.300, N.596
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain B: H.648, V.649, N.650
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain B: N.702, G.1124
- Chain C: D.789
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain B: N.1151
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain C: Y.28, N.61
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain C: Y.145, N.149
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain C: N.324, P.572, Q.573
Ligand excluded by PLIPNAG.51: 1 residues within 4Å:- Chain C: N.596
Ligand excluded by PLIPNAG.52: 1 residues within 4Å:- Chain C: N.650
Ligand excluded by PLIPNAG.53: 2 residues within 4Å:- Chain A: D.789
- Chain C: N.702
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain C: Y.1148, N.1151
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xing, X. et al., Structures of SARS-CoV-2 spike protein alert noteworthy sites for the potential approaching variants. Virol Sin (2022)
- Release Date
- 2023-09-06
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.90 Å
- Oligo State
- homo-trimer
- Ligands
- 19 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 26 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xing, X. et al., Structures of SARS-CoV-2 spike protein alert noteworthy sites for the potential approaching variants. Virol Sin (2022)
- Release Date
- 2023-09-06
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C